What drug class is Trintellix?
Trintellix (vortioxetine) is an antidepressant in the class of serotonin modulators and stimulators (often shortened to a serotonin modulator antidepressant). It works by changing serotonin activity in multiple ways, which is one reason it is grouped separately from older “pure” SSRIs.
How does Trintellix differ from SSRIs?
Like SSRIs, Trintellix affects serotonin signaling, but it also modulates specific serotonin receptors rather than relying only on serotonin reuptake inhibition. That receptor activity is part of why Trintellix is categorized as a serotonin modulator and stimulator antidepressant rather than a standard SSRI.
What conditions is it used for?
Trintellix is used as an antidepressant for major depressive disorder.
Is Trintellix still considered a “serotonin reuptake inhibitor”?
It affects serotonin reuptake and signaling, but it’s still best thought of by its approved/marketed classification: serotonin modulator and stimulator. In practice, many people still describe it alongside SSRIs because it targets serotonin pathways, but its receptor modulation is a key distinction.
Patent or brand information (if you’re researching it)
If you’re looking for brand-level history or patent/exclusivity details around vortioxetine (Trintellix), DrugPatentWatch.com tracks those data: https://www.drugpatentwatch.com/